The Centers for Disease Control and Prevention recently announced its development of a new diagnostic test to detect the presence of the dengue virus.
Earlier this week 13 pharmaceutical companies*, together with several government and nongovernmental organizations**, pledged to find solutions to eliminate or control 10 neglected tropical diseases (NTDs) by the year 2020. At an event in London, pharmaceutical companies committed to invest in research and development (R&D) to find new treatments for NTDs along with increasing donations of existing drugs.

 Last century, the invention of the outhouse helped to eliminate hookworm and other parasites in the United States. Now new research shows that the lowly latrine could be a powerful tool in controlling these diseases, which remain widespread among the world's poorest people.

Albert B Sabin is probably best known for his work and research on the polio virus. During World War II he worked on and developed vaccines for encephalitis (sleeping sickness), sand-fly fever and dengue fever as well. It is his work into dengue fever during this time that is now having possible implications for vaccine development today — 60 years later.

Last week leaders in global health and tropical medicine convened in Philadelphia to talk about the latest scientific advances in their field as well as the current status of efforts to control tropica

Great news in the world of global health! A recent clinical trial for an experimental malaria vaccine has yielded successful results in protecting a large number of children against malaria with minimal side effects.

ABC News posted a video Thursday entitled “Parasitic Worms,” which features Sabin Vaccine Institute’s Dr. David Diemert discussing Sabin Vaccine Development work in Minas Gerais, Brazil. The video, which was produced in 2010 by Rockhopper, highlights the pervasiveness of hookworm infection among children in Brazil.

Remember the last time you had the flu? The exhaustion, the fever, the aching body?

In partnership with the Fraunhofer Center for Molecular Biotechnology and the Walter Reid Army Institute for Research, the Sabin Vaccine Institute has successfully expressed the hookworm-derived antigen Na-APR-1.

Pages